Biology-Driven Phase II Trials: What Is the Optimal Model for Molecular Selection?
Author:
Affiliation:
1. L'Institut National de la Santé et de la Recherche Médicale U981, Institut Gustave Roussy, Villejuif, France
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.31.6877
Reference13 articles.
1. Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2. Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
3. Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
4. Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK
5. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
Cited by 60 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Moving toward precision medicine to predict drug sensitivity in patients with metastatic breast cancer;ESMO Open;2024-03
2. HOPE (SOLTI-1903) breast cancer study: real-world, patient-centric, clinical practice study to assess the impact of genomic data on next treatment decision-choice in patients with locally advanced or metastatic breast cancer;Frontiers in Oncology;2023-04-28
3. 18F-labeled FGFR1 peptide: a new PET probe for subtype FGFR1 receptor imaging;Frontiers in Oncology;2023-04-27
4. First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study;Frontiers in Oncology;2021-11-04
5. Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer;European Respiratory Review;2021-07-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3